Concepedia

Juerg Lehmann

JL

Statistics

Publications

8

Citations

231

H-Index

8

Active since

1978

Affiliations

Arena Pharmaceuticals (United States)(Current)

Juerg Lehmann is an author at Arena Pharmaceuticals (United States) specializing in pharmacology, medicine, and drug discovery.

Top concepts

Publications per year

1978–2015

8

Publications

8

Discovery of APD334: Design of a Clinical Stage Functional Antagonist of the Sphingosine-1-phosphate-1 Receptor

Daniel J. Buzard, Sun Hee Kim, Luis Lopez et al. · ACS Medicinal Chemistry Letters · 2014 · 70 citations · Full text

, , +20

Discovery of a second generation agonist of the orphan G-protein coupled receptor GPR119 with an improved profile

Graeme Semple, Juerg Lehmann, Amy Wong et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 51 citations · Full text

, , +9

Structural basis for constitutive activity and agonist‐induced activation of the enteroendocrine fat sensor <scp>GPR</scp>119

Maja S. Engelstoft, Christoffer Norn, M. Hauge et al. · British Journal of Pharmacology · 2014 · 31 citations · Full text

Tetrakis(acetoxymercuri)methane: a polymetallic reagent for labeling sulfur in nucleic acids.

Kenneth G. Strothkamp, Juerg Lehmann, Stephen J. Lippard · Proceedings of the National Academy of Sciences · 1978 · 19 citations · Full text

, , +15

Fused tricyclic indoles as S1P1 agonists with robust efficacy in animal models of autoimmune disease

Daniel J. Buzard, Sangdon Han, Luis Lopez et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 18 citations · Full text

, , +9

1–5 of 8